These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19077051)

  • 1. Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.
    Chen G; Wang Y; Huang H; Lin F; Wu D; Sun A; Chang H; Feng Y
    Eur J Haematol; 2009 Mar; 82(3):176-83. PubMed ID: 19077051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study on 5-azacytidine anti-myeloma activity in vitro.
    Chen GH; Wu DP; Lin FR; Wang Y; Huang HW; Chang HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):602-6. PubMed ID: 19549372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of (-)-epigallocatechin-3-gallate and 5-AZA-CdR on expression of X-linked inhibitor of apoptosis protein-associated factor 1 in human leukemia HL-60 and K562 cells].
    Huang YY; Xia Y; Guo HX; Li WY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):204-8. PubMed ID: 18250043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [5-azacytidine treatment induces tumor suppressor gene XAF1 expression and inhibits proliferation in myeloma cells].
    Chen GH; Lin FR; Wu DP; Wang Y; Huang HW; Tang XW; Zhu ZL; Feng YF; Chang WR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):229-32. PubMed ID: 19731821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
    Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
    Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.
    Rousselot P; Larghero J; Labaume S; Poupon J; Chopin M; Dosquet C; Marolleau JP; Janin A; Brouet JC; Fermand JP
    Eur J Haematol; 2004 Mar; 72(3):166-71. PubMed ID: 14962234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses.
    Chung SK; Lee MG; Ryu BK; Lee JH; Han J; Byun DS; Chae KS; Lee KY; Jang JY; Kim HJ; Chi SG
    Gastroenterology; 2007 Jun; 132(7):2459-77. PubMed ID: 17570219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-beta.
    Micali OC; Cheung HH; Plenchette S; Hurley SL; Liston P; LaCasse EC; Korneluk RG
    BMC Cancer; 2007 Mar; 7():52. PubMed ID: 17376236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome.
    Kempkensteffen C; Hinz S; Schrader M; Christoph F; Magheli A; Krause H; Schostak M; Miller K; Weikert S
    Cancer Lett; 2007 Sep; 254(2):227-35. PubMed ID: 17449173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
    Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
    Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
    Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.
    Zhang W; Wang L; Fan Q; Wu X; Wang F; Wang R; Ma Z; Yang J; Lu SH
    Oncol Rep; 2011 Sep; 26(3):621-8. PubMed ID: 21687957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid.
    Campbell RA; Sanchez E; Steinberg JA; Baritaki S; Gordon M; Wang C; Shalitin D; Chen H; Pang S; Bonavida B; Said J; Berenson JR
    Br J Haematol; 2007 Aug; 138(4):467-78. PubMed ID: 17587338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.